About CURE
The Global X S&P Biotech ETF (CURE) seeks to invest in companies that stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.
Find out what a historical investment in Global X S&P Biotech ETF would be worth today using our CURE stock calculator.
Market Capitalisation
$48.23M
Price-earnings ratio
2.14
Dividend yield
0.00%
High today
$75.22
Low today
$74.83
Open price
$75.16
52-week high
$81.49
52-week low
$54.57
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CURE
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in CURE on Stake
- Buy CURE from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
CURE related stocks